Safety

News

Colleagues discuss information on a laptop screen

EVERSANA unveils new AI-powered pharmacovigilance suite

EVERSANA has launched a new pharmacovigilance platform to answer the need for advanced analytics and AI in drug safety monitoring and risk management.

News

FDA clears new, safer regimen for Lilly's Alzheimer's drug

Eli Lilly has won FDA approval for a new regimen for its Alzheimer's disease therapy Kisunla, which carries a reduced risk of side effects.

News

FDA loosens restrictions on first-gen CAR-T therapies

There is enough experience with the first wave of autologous CAR-T therapies to allow strict rules ensuring their safe use to be relaxed, says FDA.

News

MHRA's chief safety officer, Dr Alison Cave

UK probes link between GLP-1 drugs and pancreatitis

The UK is studying cases of pancreatitis in people taking GLP-1 drugs for weight loss or type 2 diabetes to see if genetics may make them vulnerable.

News

FDA probing deaths with DMD gene therapy Elevidys

The FDA has launched a formal investigation into two liver failure-related deaths in patients treated with Duchenne gene therapy Elevidys.

News

UK regulator overhauls medical device regulation

Major changes to medical device regulations in the UK have come into force with an overhaul of post-market surveillance requirements.

EVERSANA unveils new AI-powered pharmacovigilance suite

FDA clears new, safer regimen for Lilly's Alzheimer's drug

FDA loosens restrictions on first-gen CAR-T therapies

UK probes link between GLP-1 drugs and pancreatitis

FDA probing deaths with DMD gene therapy Elevidys

UK regulator overhauls medical device regulation

Remepy's hybrid Parkinson's therapy poised for phase 3

Discover a new era of healthcare panel engagement: Grounded ...

Safety

Editor's Picks